355TiPPhase III clinical trials of atezolizumab compared with standard chemotherapy in PD-L1–selected chemotherapy-naïve patients with advanced NSCLC:
Herbst, R.S., de Marinis, F., Jassem, J., Spigel, D.R., Shankar, G., Mocci, S., Sandler, A., Lopez-Chavez, A., Li, S., Giaccone, G.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv528.12
Date:
December, 2015
File:
PDF, 33 KB
english, 2015